RF energy is widely used to coagulate, cut or ablate tissue. In both modalities, monopolar and bipolar, conductive electrodes contact the tissue to be treated. In the monopolar mode, the active electrode is placed in contact with the tissue to be treated and a return electrode with a large surface area is located on the patient at a distance from the active electrode. In the bipolar mode, the active and return electrodes are in close proximity to each other bracketing the tissue to be treated. Sometimes an array of electrodes is used to provide better control over the depth of penetration of the RF field and hence control over the temperatures to which the tissue is heated.
There are a number of disadvantages with each mode. For example, in the monopolar arrangement, because of the large physical separation between the electrodes there are frequent reports of local burning at the electrode sites. For example, this would clearly be undesirable where one of the electrodes will be inside a blood vessel. The other serious issue is the likelihood of forming blood clots. The tissue that is in contact with the electrodes can be coagulated or ablated. In the case of the electrodes being present inside a blood vessel, the formation of dangerous blood clots is undesireable.
In an attempt to overcome the issues described above, various devices and electrode configurations are described in the following patents. U.S. Pat. Nos. 5,366,443 and 5,419,767 describe the use of RF electrodes on a catheter to cross a lesion. These patents describe a bipolar electrode assembly at the distal tip of a catheter that is in contact with the occlusion. The application of RF energy ablates the occlusion and renders the occlusion susceptible for the guidewire to penetrate. This method has the drawback that careful tracking of the occlusion and the ablation process is necessary to avoid trauma to the vessel walls or healthy tissue, since the possibility of short-circuiting of current through healthy tissue instead of the occlusion is high. U.S. Pat. No. 5,419,767 overcomes this limitation to a certain extent through the use of a multiple electrode array. However, this device requires a channel to be pre-created through the occlusion so that the device can be passed through a guidewire traversing this channel.
The present technology is directed to overcoming these and other deficiencies in the art.
A tissue ablation device includes a first longitudinal member having a first end configured to be coupled to an energy generator and a second end comprising a first plurality of electrodes that are expandable about a central axis of the first longitudinal member. A second longitudinal member having a first end configured to be coupled to the energy generator and a second end comprising at least one electrode is nested within the first longitudinal member.
A method for ablating a tissue includes advancing a first longitudinal member and a second longitudinal member nested within the first longitudinal member into a tissue region of a body of a patient. The first longitudinal member comprises a first end configured to be coupled to an energy generator and a second end comprising a first plurality of electrodes that are expandable to change the respective positioning between the plurality of electrodes. The second longitudinal member comprises a first end configured to be coupled to the energy generator and a second end comprising at least one electrode. The first plurality of electrodes are expanded to provide a bipolar arrangement between the first plurality of electrodes of the first longitudinal member and the at least one electrode of the second longitudinal member. A delivery of energy to the first and second longitudinal members is initiated from the energy generator to the tissue region of the body to ablate the tissue.
Methods, devices, and systems according to the exemplary embodiments of the present technology provide for bi-polar ablation of tissue. For example, one exemplary application of the present technology is to ablate prostate tissue to relieve the symptoms of conditions such as benign prostatic hyperplasia (BPH) and prostatic carcinoma, where enlargement of the prostate can obstruct the urethra and result in compression and partial or total occlusion of the urethra. As symptoms of prostatic disorders such as BPH often result in obstruction of the urethra, any trans-urethral prostatic treatment methods and devices are likely to be hindered by abnormal tissue occlusion. This is because the device may not be able to properly move within the occluded space to treat the desired area, thus preventing treatment devices from functioning properly or optimally. It is an advantageous aspect of the present technology that it allows resection of tissue, such as prostate tissue, via bi-polar tissue ablation to ablate tissue to weaken, alter, or otherwise treat the tissue instead of, or prior to, surgical resection. Treatments such as tissue ablation could be used to weaken the target tissue by essentially detaching it from the tissue matrix of a body region and thereby allowing easy removal of the treated tissue. More specifically, aspects of the present technology use energy delivered through two longitudinal members for tissue ablation and for recanalization of occluded lumens.
Another exemplary application of the present technology is to ablate a vascular occlusion, such as chronic total occlusions (CTO) or cerebral clots or grafts, such as hemodialysis grafts. Further aspects of the present technology may be employed to ablate other tissues, such as a cardiac structure including, for example, the interatrial septum.
This technology provides a number of advantages including providing safe and effective devices and methods for bi-polar tissue ablation.
An exemplary tissue ablation system 5 is illustrated in
Referring again to
As indicated in
In this example, energy generator 10 (also referred to as a controller) is an RF energy generator that serves as a source of RF energy to be provided to the first longitudinal member 100a and the second longitudinal member 100b. Optionally, in one example the energy generator 10 is a hand-held battery-operated device, although other types of RF generators may be utilized. While the use of RF energy from energy generator 10 for the purpose of ablation is described herein, it should be noted that other energy modalities may be used as well, for example ultrasound energy. In one example, one or both of first longitudinal member 100a and second longitudinal member 100b of the exemplary tissue ablation system 5 of the present technology comprise one or more ultrasound transducers configured to be coupled to the energy generator 10, instead of or in addition to RF electrodes as described below. The ultrasound transducers provide ultrasound energy for ablating an occlusion. In another example, both the first longitudinal member 100a and the second longitudinal member 100b comprise ultrasound transducers and ablate the lesion from an antegrade as well as a retrograde direction. Other energy modalities could include microwave and laser, although additional energy modalities known in the art may be employed.
Referring again to
As shown in
In this example, conductive wires (not shown) connect the electrodes 105a and 105b to the connector 30 to deliver RF energy, by way of example only, from the energy generator 10 to the electrodes 105a and 105b. The exterior of the first longitudinal member 100a and the second longitudinal member 100b are covered by non-conductive layers 115a and 115b, respectively, which sandwich the conductive wires between the first longitudinal member 100a and the second longitudinal member 100b and the non-conductive layers 115a and 115b. In one example, the non-conductive layers 115a and 115b comprise a sheath or a coating. Exemplary materials that may be utilized for the non-conductive layers 115a and 115b may include Teflon, ceramic, polyimide, parylene, or other suitable materials. Exemplary methods that can be employed for coating may include spraying, dipping, vapor deposition, or plasma deposition.
In this example, as further shown in
Referring again to
In one embodiment, the energy generator 10 is capable of measuring the impedance of the tissue between the two electrodes 105a and 105b. Based on the type of the tissue to be ablated, the user can choose the appropriate combination of temperature, treatment time, and the amount of RF energy to be provided to the tissue to achieve a safe and effective treatment. Alternatively, the treatment may proceed with the user manually controlling the parameters during the recanalization procedure, with the user treating the occlusion until recanalization is achieved.
It is noted that energizing an electrode with radiofrequency energy causes the electrode to generate heat. In general, the amount of such heat is proportional to the amount of radiofrequency energy delivered to the electrode, and inversely proportional to the surface area of the electrode. This is because the smaller the surface area of an electrode, the higher the current density passing through that surface area (for a given total current), which in turn causes the electrode to reach correspondingly higher temperatures. In one example, electrodes having sharp points configured to generate a high current density may be employed. By way of example only, ball tip electrodes may be utilized to generate areas of high current density in examples employing radiofrequency energy. In one example, the system is configured to deliver sufficient radiofrequency energy to an electrode such that radiofrequency sparks are generated.
Referring now to
In another example, as shown in
While it is possible to have the surface areas of the active and return electrodes be of similar size, in one example an active electrode is configured to have a smaller surface area than a return electrode. This allows the active electrode to generate a current density that is sufficiently high to cause radiofrequency sparks crossing over to the return electrode, while at the same time allowing the return electrode surface area to be sufficiently large so as to maximize its contact with the occlusion and attract sparks from the active electrode. Another advantage of such an embodiment is that the return electrode will likely not reach as high temperatures as the active electrode. In one example, the ratio of the return electrode surface area to the active electrode surface area is configured to be in the range of about 50:1 to 2:1, and preferably about 10:1. In another example, the return electrode is configured in a pigtail design to increase surface area contact with the occlusion.
In another example, such as illustrated in
In one example, each of the plurality of electrodes 310, or ribs, comprises an electrode area 330 adjacent to an insulator area 340, as shown in the cross-sectional view of
In another example, the electrode areas are confined or concentrated to a portion of the ribs. Confining the electrode areas to a portion of the rib allows for a higher current density at the site of the electrode to more effectively ablate the targeted tissue. In one example, one or more ribs that comprise one or more ball tip electrodes on the inside of the ribs are utilized. In this example, the one or more ball tips are configured as points where energy is transmitted. Alternatively, it is contemplated that in other examples the placement of the electrode areas 330 and insulator areas 340 may be varied. In an optional example, a capture device may be configured to comprise one or more electrode areas for use as return electrodes. Examples of capture devices are disclosed in U.S. Pat. No. 9,119,651, the disclosure of which is hereby incorporated by reference herein in its entirety. In yet an additional optional example, a capture device comprising an aspiration catheter is incorporated to aspirate any residual debris from the ablation. Furthermore, the basket-like configuration, especially when expanded may serve as a stabilization element by anchoring the longitudinal member within the tissue region.
In another example, as seen in
The longitudinal members 410 and 420 comprise conductive electrodes 411 and 421, respectively, located at their distal ends, although the longitudinal members 410 and 420 may have other types and numbers of electrodes in other locations. In this example, the two longitudinal members 410 and 420 may be advanced into the tissue region in tandem. Once the two longitudinal members 410 and 420 are near the target tissue, as seen in
In another example, as seen in
In this example, contemporaneously or sequentially with the deployment of the first longitudinal member 510, the plurality of electrodes 540 configured as ribs 541 of the second longitudinal member 520 are configured to transform from a collapsed state to the expanded state as described above. In one example, the one or more ribs comprises one or more ball tips 541a on the inside of the ribs that serve as the electrodes. In one example, the ball tips 541a are configured as points where energy is transmitted with a high current density, although other electrode configurations that provide sharp points to create high current densities may be employed. Thereafter, the two longitudinal members 510 and 520 form a bi-polar configuration such that a portion of the target tissue between or near the first and the second longitudinal members 510 and 520 is subject to ablation when energy is delivered between the two longitudinal members 510 and 520 via the plurality of electrodes 540 disposed on the second longitudinal member 520 and the electrode 530 on the first longitudinal member 510. In another example, the two longitudinal members 510 and 520 are separately advanced to the target tissue.
In one aspect of the nested examples illustrated in
In another example, as seen in
Thereafter, the two longitudinal members 610 and 620 form the bi-polar configuration such that a portion of the target tissue between or near the first and the second longitudinal members 610 and 620 is subject to ablation when energy is delivered between the two longitudinal members 610 and 620 via the plurality of electrodes 630 and 640.
In yet another example, a single longitudinal member comprises two sets of the plurality of electrodes configured to expand outwardly in a basket-like configuration in the expanded configuration. The first basket of the plurality of electrodes is configured to be nested within the second basket of the plurality of electrodes. In this configuration, the two baskets of electrodes form the bi-polar configuration such that a portion of the target tissue between the two baskets are subject to ablation when energy is delivered between the two baskets of electrodes.
While the present embodiments have been described primarily with reference to transurethral treatment of the prostate, it is contemplated that certain aspects of the embodiments may also be used to treat and modify other organs such as brain, heart, lungs, intestines, eyes, skin, kidney, liver, pancreas, stomach, uterus, ovaries, testicles, bladder, ear, nose, etc., soft tissues such as bone marrow, adipose tissue, muscle, glandular tissue, spinal tissue, etc., hard biological tissues such as teeth, bone, etc., as well as body lumens and passages such as the sinuses, ureter, colon, esophagus, lung passages, blood vessels, etc. The devices disclosed herein may be inserted through an existing body lumen, or inserted through solid body tissue.
Another aspect of the present invention relates to the delivery of energy in the bipolar arrangement. In particular, the energy can be delivered sequentially to each individual rib in an array so as to concentrate energy deliver between a first electrode on the nested longitudinal member and a second electrode located on an individual rib. Energy is delivered sequentially to each individual rib in a circular fashion so as to scan 360 degrees within the targeted tissue. Alternatively, the energy can be delivered contemporaneously.
An exemplary operation of the tissue ablation system 5 to perform an exemplary method for ablating a tissue will now be described with reference to
First the longitudinal members 510 and 520 are delivered into a tissue region of a body of a patient, such as prostrate tissue or a vascular occlusion by way of example only, with the longitudinal member 510 nested within the longitudinal member 520. The longitudinal members 510 and 520 are coupled to the energy generator 10, such as a radiofrequency energy generator. The longitudinal member 510 comprises a single electrode 530 on its distal end, while the longitudinal member 520 includes a plurality of expandable electrodes 540 on its distal end.
Next, the plurality of electrodes 540 on the longitudinal member 520 are expanded to provide a bipolar arrangement between the plurality of electrodes 540 of the longitudinal member 520 and the electrode 530 of the longitudinal member 510. By way of example only, the plurality of electrodes 540 may be expanded into a basket-like configuration, although other expanded configurations, such as a helical coil may be utilized. In another example, a plurality of ribs 541 with electrodes configured to generate a high current density such as ball-tip electrodes 541a may be employed for the basket-like configuration. In one example, either concurrently or sequentially with expanding the plurality of electrodes 540, the longitudinal member 510 may be extended from its nested position in the longitudinal member 520 to alter the distance between the electrode 530 and the plurality of electrodes 540 prior to tissue ablation.
A delivery of energy to the longitudinal members 510 and 520 from the energy generator 10 to the tissue region of the body is then initiated to ablate the tissue. In one example, the energy is radiofrequency energy, although other energy modalities may be used. The position of the of the longitudinal member 510 from its nested position in longitudinal member 520 may be adjusted to change the area of tissue ablated by the delivery of energy.
Having thus described the basic concept of the invention, it will be rather apparent to those skilled in the art that the foregoing detailed disclosure is intended to be presented by way of example only, and is not limiting. Various alterations, improvements, and modifications will occur and are intended to those skilled in the art, though not expressly stated herein. These alterations, improvements, and modifications are intended to be suggested hereby, and are within the spirit and scope of the invention. Additionally, the recited order of processing elements or sequences, or the use of numbers, letters, or other designations therefore, is not intended to limit the claimed processes to any order except as may be specified in the claims. Accordingly, the invention is limited only by the following claims and equivalents thereto.
This application claims priority benefit of U.S. Provisional Patent Application Ser. No. 62/360,911, filed Jul. 11, 2016, which is hereby incorporated by reference in its entirety. The present invention relates generally to medical methods and devices. In particular, the present invention relates to a bi-polar tissue ablation device and methods of use thereof
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US17/41541 | 7/11/2017 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62360911 | Jul 2016 | US |